Search Results - "Upadhyay, Sameer"

Physiological and molecular implications of multiple abiotic stresses on yield and quality of rice by Radha, Beena, Sunitha, Nagenahalli Chandrappa, Sah, Rameswar P, T P, Md Azharudheen, Krishna, G K, Umesh, Deepika Kumar, Thomas, Sini, Anilkumar, Chandrappa, Upadhyay, Sameer, Kumar, Awadhesh, Ch L N, Manikanta, S, Behera, Marndi, Bishnu Charan, Siddique, Kadambot H M

“…Abiotic stresses adversely affect rice yield and productivity, especially under the changing climatic scenario. Exposure to multiple abiotic stresses acting…”
Get full text

Genetic analysis and trait association for yield related traits in F2: 3 biparental population of rice under slightly sodic condition by Bisen, Prashant, Singh, P. K., Loitongbam, Bapsila, Namrata, Rathi, Sanket R., Upadhyay, Sameer, Sinha, B.

“…Genetic variability and correlation studies provide basic information concerning the genetic properties of the population based on which, breeding methods…”
Get full text

Safety, tolerability, and pharmacokinetics of casimersen in patients with Duchenne muscular dystrophy amenable to exon 45 skipping: A randomized, double‐blind, placebo‐controlled, dose‐titration trial by Wagner, Kathryn R., Kuntz, Nancy L., Koenig, Erica, East, Lilly, Upadhyay, Sameer, Han, Baoguang, Shieh, Perry B.

“…Introduction/Aims Duchenne muscular dystrophy (DMD) is caused by mutations in the DMD gene resulting in the absence of dystrophin. Casimersen is a…”
Get full text

Casimersen treatment in eligible patients with Duchenne muscular dystrophy: safety, tolerability, and pharmacokinetics over 144 weeks of treatment by Kuntz, Nancy, Wagner, Kathryn, East, Lilly, Upadhyay, Sameer, Han, Baoguang, Koenig, Erica, O’Rourke, Erin, Shieh, Perry

Get full text

eP152 - Casimersen treatment in eligible patients with Duchenne muscular dystrophy: safety, tolerability, and pharmacokinetics over 144 weeks of treatment by Kuntz, Nancy, Wagner, Kathryn, East, Lilly, Upadhyay, Sameer, Han, Baoguang, Koenig, Erica, O’Rourke, Erin, Shieh, Perry

Get full text

Safety, tolerability, and pharmacokinetics of casimersen in patients with D uchenne muscular dystrophy amenable to exon 45 skipping: A randomized, double‐blind, placebo‐controlled, dose‐titration trial by Wagner, Kathryn R., Kuntz, Nancy L., Koenig, Erica, East, Lilly, Upadhyay, Sameer, Han, Baoguang, Shieh, Perry B.

“…Abstract Introduction/Aims Duchenne muscular dystrophy (DMD) is caused by mutations in the DMD gene resulting in the absence of dystrophin. Casimersen is a…”
Get full text

Genome-wide association analysis for plant type characters and yield using cgSSR markers in rice (Oryza sativa L.) by Muhammed Azharudheen, T. P., Nayak, Amrit Kumar, Behera, Sasmita, Anilkumar, C., Marndi, Bishnu Charan, Moharana, Debashis, Singh, Lalan Kumar, Upadhyay, Sameer, Sah, Rameswar Prasad

“…Plant architecture has a substantial impact on photosynthesis, which leads to increased yield production. Many plant architecture characters are quantitative…”
Get full text

Identification of QTLs for zinc deficiency tolerance in a recombinant inbred population of rice (Oryza sativa L.) by Loitongbam, Bapsila, Singh, Pawan Kumar, Sah, Rameswar Prasad, Verma, Om Prakash, Singh, Balwant, Bisen, Prashant, Kulhari, Sandhya, Rathi, Sanket R, Upadhyay, Sameer, Singh, Nagendra Kumar, Sahu, Rabin, Singh, Rakesh Kumar

“…BACKGROUND Deficiency of Zn is a major soil constraint in rice plant growth and yield. Edaphic factors such as Zn deficiency in soil in relation to plant…”
Get full text

A Multicenter Randomized, Double-Blind, Placebo-Controlled, Gene-Delivery Clinical Trial of rAAVrh74.MHCK7.micro-dystrophin for Duchenne Muscular Dystrophy (4478) by Mendell, Jerry, Shieh, Perry, Sahenk, Zarife, Lehman, Kelly, Lowes, Linda, Miller, Natalie, Iammarino, Megan, Alfano, Lindsay, Woods, Jeremy, Skura, Christy, Mao, Howard, Staudt, Loretta, Potter, Rachael, Griffin, Danielle, Lewis, Sarah, Hu, Larry, Upadhyay, Sameer, Singh, Teji, Rodino-Klapac, Louise

“…Abstract only…”
Get full text

A Phase 2 Clinical Trial Evaluating the Safety and Efficacy of SRP-9001 for Treating Patients with Duchenne Muscular Dystrophy (S23.002) by Mendell, Jerry R., Shieh, Perry B., Sahenk, Zarife, Lehman, Kelly J., Lowes, Linda P., Reash, Natalie F., Iammarino, Megan A., Alfano, Lindsay N., Powers, Brenna, Woods, Jeremy D., Skura, Christy L., Mao, Howard C., Staudt, Loretta A., Potter, Rachael A., Griffin, Danielle A., Lewis, Sarah, Hu, Larry, Upadhyay, Sameer, Singh, Teji, Rodino-Klapac, Louise R.

“…Abstract only…”
Get full text

eP201: A phase 2 clinical trial evaluating the safety and efficacy of delandistrogene moxeparvovec for treating patients with Duchenne muscular dystrophy by O'Rourke, Erin, Mendell, Jerry, Shieh, Perry, Sahenk, Zarife, Lehman, Kelly, Lowes, Linda, Reash, Natalie, Iammarino, Megan, Alfano, Lindsay, Powers, Brenna, Woods, Jeremy, Skura, Christy, Mao, Howard, Staudt, Loretta, Potter, Rachael, Griffin, Danielle, Lewis, Sarah, Upadhyay, Sameer, Singh, Teji, Rodino-Klapac, Louise

Get full text

Safety of celecoxib compared with placebo and non-selective NSAIDs: cumulative meta-analysis of 89 randomized controlled trials by Essex, Margaret Noyes, Zhang, Richard Y, Berger, Manuela F, Upadhyay, Sameer, Park, Peter W

“…Further understand the safety profile of celecoxib and provide safety information for important adverse events (AEs). Analysis of randomized controlled trials…”
Get more information